Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Leukocyte- and Platelet-Rich Fibrin in the Surgical Treatment of Medication-related Osteonecrosis of the Jaw: a Randomized Controlled Trial

NCT06419010 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT06419010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06419010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Leukocyte- and Platelet-Rich Fibrin in the Surgical Treatment of Medication-related Osteonecrosis of the Jaw: a Randomized Controlled Trial
Lead sponsor
University Hospital, Toulouse
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 31, 2024
Completion date
May 31, 2027
Enrollment
150 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

osteonecrosis of the jaw